| 1 |
34903590 | Intersystem Extrapolation Factors Are Substrate-Dependent for CYP3A4: Impact on Cytochrome P450 Reaction Phenotyping. | 2022 Mar |
2 |
| 2 |
34335273 | Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. | 2021 |
1 |
| 3 |
31359271 | Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes. | 2020 Jan |
2 |
| 4 |
32276526 | Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia. | 2020 Apr 8 |
1 |
| 5 |
32446424 | High Doses of Drugs Extensively Metabolized by CYP3A4 Were Needed to Reach Therapeutic Concentrations in Two Patients Taking Inducers. | 2020 Apr - Jun |
1 |
| 6 |
32519344 | CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta-analysis. | 2020 Jul |
1 |
| 7 |
29055041 | The possible clinical impact of risperidone on P-glycoprotein-mediated transport of tacrolimus: A case report and in vitro study. | 2018 Jan |
1 |
| 8 |
29869546 | The Use of Carbamazepine to Expedite Metabolism of Risperidone Long-Acting Injection Through Induction of CYP3A4 in a Patient With Extrapyramidal Symptoms. | 2018 Jun 1 |
1 |
| 9 |
27993531 | Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolism. | 2017 Jul |
1 |
| 10 |
28160505 | Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy. | 2017 Aug |
1 |
| 11 |
27251417 | Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions. | 2016 Aug |
1 |
| 12 |
25868121 | The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients. | 2015 Jun |
1 |
| 13 |
26387027 | Evaluation of potential pharmacokinetic drug-drug interaction between armodafinil and risperidone in healthy adults. | 2015 Nov |
1 |
| 14 |
21518375 | Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers. | 2012 Apr |
4 |
| 15 |
28520384 | Risperidone Therapy and CYP2D6 Genotype | 2012 |
1 |
| 16 |
19395426 | Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients. | 2010 Jul |
3 |
| 17 |
18094221 | Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone. | 2008 Jan |
2 |
| 18 |
18537577 | Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. | 2008 Jun |
1 |
| 19 |
18691984 | Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophrenia. | 2008 Jul |
1 |
| 20 |
17214606 | Metabolic drug interactions with newer antipsychotics: a comparative review. | 2007 Jan |
1 |
| 21 |
17381666 | Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers. | 2007 Apr |
2 |
| 22 |
15883149 | The dosing of atypical antipsychotics. | 2005 May-Jun |
2 |
| 23 |
15910772 | Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. | 2005 May 31 |
1 |
| 24 |
16226034 | Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia. | 2005 Dec |
1 |
| 25 |
16321618 | Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients. | 2005 Nov |
4 |
| 26 |
15270204 | The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions. | 2004 Aug |
1 |
| 27 |
12665390 | Fatalities associated with therapeutic use and overdose of atypical antipsychotics. | 2003 |
1 |
| 28 |
12670127 | Interactions between the cytochrome P450 system and the second-generation antipsychotics. | 2003 Mar |
1 |
| 29 |
11978161 | Extrapyramidal symptoms with ritonavir/indinavir plus risperidone. | 2002 May |
1 |
| 30 |
12172343 | Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction. | 2002 Aug |
1 |
| 31 |
12186270 | New antipsychotic agents for schizophrenia: pharmacokinetics and metabolism update. | 2002 Jul |
2 |
| 32 |
11476125 | An evaluation of risperidone drug interactions. | 2001 Aug |
1 |
| 33 |
11560868 | Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. | 2001 Oct |
2 |
| 34 |
10771452 | Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions. | 2000 |
2 |
| 35 |
10843459 | Biotransformation of post-clozapine antipsychotics: pharmacological implications. | 2000 May |
2 |
| 36 |
10942191 | Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate. | 2000 Aug |
1 |
| 37 |
10048600 | Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. | 1999 Feb |
1 |
| 38 |
10422890 | Drug metabolism and atypical antipsychotics. | 1999 Jun |
1 |
| 39 |
10453802 | A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A. | 1999 Jul |
3 |
| 40 |
9231305 | Erythromycin interaction with risperidone or clomipramine in an adolescent. | 1996 Summer |
1 |